Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_1
1
13%
Ph not_applicable
7
88%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
N/ANon-phased studies
7(87.5%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Active(3)
Completed(3)
Terminated(2)

Detailed Status

Completed3
Enrolling by invitation3
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
75.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (12.5%)
N/A7 (87.5%)

Trials by Status

terminated113%
completed338%
enrolling_by_invitation338%
withdrawn113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DEVICE
Total Trials
8